We are live on ! Find out more
ITP

Iron Triangle Partners Portfolio holdings

AUM $875M
1-Year Est. Return 49.85%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$572M
AUM Growth
-$199M
Cap. Flow
-$206M
Cap. Flow %
-35.93%
Top 10 Hldgs %
54.05%
Holding
34
New
9
Increased
5
Reduced
12
Closed
7

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$43.6M
2
SNY icon
Sanofi
SNY
+$40.1M
3
HCA icon
HCA Healthcare
HCA
+$27.9M
4
CTLT
CATALENT, INC.
CTLT
+$24.8M
5
NARI
Inari Medical, Inc. Common Stock
NARI
+$22.3M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$53.6M
2
RGEN icon
Repligen
RGEN
+$31.6M
3
HUM icon
Humana
HUM
+$31.6M
4
DXCM icon
DexCom
DXCM
+$29.6M
5
AZN icon
AstraZeneca
AZN
+$28.9M

Sector Composition

Rank Sector Weight
1 Healthcare 98.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OHPAU
26
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$9.87M 1.72%
999,513
– –
STXS icon
27
Stereotaxis
STXS
$130M
$3.05M 0.53%
1,696,599
-10,089
-0.6% -$21.6K
ABBV icon
28
AbbVie
ABBV
$454B
– –
-350,000
Closed -$53.6M
AZN icon
29
AstraZeneca
AZN
$263B
– –
-218,739
Closed -$28.9M
CNMD icon
30
CONMED
CNMD
$1.31B
– –
-260,000
Closed -$24.9M
KPTI icon
31
Karyopharm Therapeutics
KPTI
$161M
– –
-73,333
Closed -$4.96M
LEGN icon
32
Legend Biotech
LEGN
$3.73B
– –
-495,329
Closed -$27.2M
SPY icon
33
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
– –
-400,000
Closed -$151M
SLGC
34
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-1,000,000
Closed -$4.52M
1
2

Similar funds

8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
MFG
MidWestOne Financial Group Iowa City, Iowa $900M AUM 23.95% 1-Year Est. Return
NP
Ninepoint Partners Toronto, Ontario, Canada $904M AUM 39.64% 1-Year Est. Return
GGI
Galaxy Group Investments New York $843M AUM 47.48% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $967M AUM
OBWP
O'Brien Wealth Partners Waltham, Massachusetts $756M AUM 13.93% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $693M AUM 17.6% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Iron Triangle Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Iron Triangle Partners held 34 positions worth $572M, down 26% from $771M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Iron Triangle Partners withdrew a net $206M in Q3 2022, closing 7 positions and reducing 12 holdings. Its most notable exit was AbbVie, an estimated $53.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 79% a quarter earlier.

Against the trend, Iron Triangle Partners opened a new position in Charles River Laboratories worth $39.8M.

  • Iron Triangle Partners's largest Q3 2022 buy was Charles River Laboratories: 202,000 shares worth $39.8M.
  • Iron Triangle Partners added most to Cigna in Q3 2022, an estimated $17.7M increase.
  • Iron Triangle Partners's biggest Q3 2022 reduction was Repligen, cutting an estimated $31.6M.
  • Iron Triangle Partners fully exited AbbVie in Q3 2022, selling an estimated $53.6M.
  • Iron Triangle Partners's ten largest holdings make up 54% of its $572M portfolio in Q3 2022.
  • Iron Triangle Partners opened 9 new positions and closed 7 in Q3 2022.
  • Iron Triangle Partners's portfolio value fell 26% quarter-over-quarter to $572M.

Based on Iron Triangle Partners's 13F filing for Q3 2022, filed 14 Nov 2022.